“…Recently, B cells are increasingly recognized as an important part of the infiltrating immune compartment in autoimmune and inflammatory skin diseases. B cell numbers are elevated in lesional skin relative to control skin specimens in a number of inflammatory diseases, including, but not limited to, psoriasis (47), pemphigus (18), lupus profundus (19,20), systemic sclerosis (scleroderma) (48), discoid lupus erythematosus (49,50), Sjögren's syndrome (51), IgG4related skin diseases (33,34), atopic dermatitis (52), and allergic contact dermatitis (53). Although an increase in skininfiltrating B cells already suggested a role for B cells in cutaneous inflammation, the therapeutic success of systemic B cell depletion with rituximab confirmed a pathogenic role for B cells in a number of these diseases (54)(55)(56).…”